Authors: Lakasing, L Khamashta, M

Citation: L. Lakasing et M. Khamashta, Contraceptive practices in women with systemic lupus erythematosus and/or antiphospholipid syndrome: What advice should we be giving?, J FAM PLAN, 27(1), 2001, pp. 7

Authors: Lakasing, L Campa, JS Parmar, K Poston, R Hunt, BJ Poston, L

Citation: L. Lakasing et al., Normal expression of cell adhesion molecules in placentae from women with systemic lupus erythematosus and the antiphospholipid syndrome, PLACENTA, 21(2-3), 2000, pp. 142-149

Authors: Lakasing, L Bewley, S Nelson-Piercy, C

Citation: L. Lakasing et al., The management of antiphospholipid syndrome in pregnancy, HUGHES SYNDROME: ANTIPHOSPHOLIPID SYNDROME, 2000, pp. 397-407

Authors: Lakasing, L Spencer, JAD

Citation: L. Lakasing et Jad. Spencer, Continuation of pregnancy after mid-trimester gemeprost administration, BR J OBST G, 106(12), 1999, pp. 1319-1320

Authors: Lakasing, L Campa, JS Poston, R Khamashta, MA Poston, L

Citation: L. Lakasing et al., Normal expression of tissue factor, thrombomodulin, and annexin V in placentas from women with antiphospholipid syndrome, AM J OBST G, 181(1), 1999, pp. 180-189